Predemtec GmbH

"The test developed with the help of ILB and HTGF support enables the determination of Alzheimer's disease with a specificity and sensitivity of more than 90 percent through the immunological determination of six biomarkers in blood. The test also enables differential diagnosis of vascular dementia."

Dr. Patrick Scotten, Co-founder, Predemtec GmbH

Company details
Name/legal form Predemtec GmbH
Sector Biotechnology
Business Research, development and marketing of platforms for dementia diagnostics and research into new types of treatment for dementia
Founding team Dr. Annegret Feuerhelm-Heidl, Prof. Dr. Asmus Finzen, Dr. Patrick Scotten
Established 15 August 2011
CEO(s) Dr. Annegret Feuerhelm-Heid
Support details
Project Development of an in-vitro test for early diagnosis of Alzheimer's disease and other forms of dementia
Support programmes GRW-G, Gründung innovativ, Innovationsgutschein
Year 2013, 2014, 2015

Predemtec GmbH
Neuendorfstraße 18a, 16761 Hennigsdorf bei Berlin
Contact: Dr. Annegret Feuerhelm-Heidl
Telephone: +49 (0)3302 559 170
E-Mail: info@predemtecdx.com

  • Christina Arend Christina Arend Strategic Investments/ Start-up Initiatives
    Project Manager
    Tel.: 0331 660-1430
    Fax: 0331 660-61430
    E-Mail Kontakt
  • Petra Quehl Petra Quehl Strategic Investments/ Start-up Initiatives
    Project Coordinator
    Tel.: 0331 660-1799
    Fax: 0331 660-61799
    E-Mail Kontakt